These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8187811)

  • 1. Serum levels of interleukin-6 and tumour-necrosis-factor-alpha are not correlated to disease activity in patients with rheumatoid arthritis after treatment with low-dose methotrexate.
    Wascher TC; Hermann J; Brezinschek R; Brezinschek HP; Wilders-Truschnig M; Rainer F; Krejs GJ
    Eur J Clin Invest; 1994 Jan; 24(1):73-5. PubMed ID: 8187811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
    Barrera P; Boerbooms AM; Janssen EM; Sauerwein RW; Gallati H; Mulder J; de Boo T; Demacker PN; van de Putte LB; van der Meer JW
    Arthritis Rheum; 1993 Aug; 36(8):1070-9. PubMed ID: 8393676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression.
    Nishina N; Kaneko Y; Kameda H; Kuwana M; Takeuchi T
    Clin Rheumatol; 2013 Nov; 32(11):1661-6. PubMed ID: 23754245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate chronotherapy is effective against rheumatoid arthritis.
    To H; Yoshimatsu H; Tomonari M; Ida H; Tsurumoto T; Tsuji Y; Sonemoto E; Shimasaki N; Koyanagi S; Sasaki H; Ieiri I; Higuchi S; Kawakami A; Ueki Y; Eguchi K
    Chronobiol Int; 2011 Apr; 28(3):267-74. PubMed ID: 21452922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 6 (IL-6) and soluble IL-2 receptor levels in patients with rheumatoid arthritis treated with low dose oral methotrexate.
    Crilly A; McInness IB; McDonald AG; Watson J; Capell HA; Madhok R
    J Rheumatol; 1995 Feb; 22(2):224-6. PubMed ID: 7738942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
    Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
    J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy.
    Visvanathan S; Wagner C; Rojas J; Kay J; Dasgupta B; Matteson EL; Mack M; Baker DG; Rahman MU
    J Rheumatol; 2009 Jul; 36(7):1371-9. PubMed ID: 19487269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.
    Macías I; García-Pérez S; Ruiz-Tudela M; Medina F; Chozas N; Girón-González JA
    J Rheumatol; 2005 Nov; 32(11):2102-8. PubMed ID: 16265686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.
    Hjeltnes G; Hollan I; Førre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
    Clin Exp Rheumatol; 2013; 31(3):415-21. PubMed ID: 23465067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of inflammatory cytokines in patients with rheumatoid arthritis].
    Kang SY; Kim MH; Lee WI
    Korean J Lab Med; 2010 Jun; 30(3):301-6. PubMed ID: 20603592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis.
    Spadaro A; Taccari E; Riccieri V; Sensi F; Sili Scavalli A; Zoppini A
    Rev Rhum Engl Ed; 1997 Feb; 64(2):89-94. PubMed ID: 9085442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells.
    Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Baggiolini M; Gerber NJ
    Br J Rheumatol; 1995 Jul; 34(7):602-9. PubMed ID: 7670776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis.
    Arvidson NG; Gudbjörnsson B; Elfman L; Rydén AC; Tötterman TH; Hällgren R
    Ann Rheum Dis; 1994 Aug; 53(8):521-4. PubMed ID: 7944637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
    Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
    Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis.
    Barrera P; Haagsma CJ; Boerbooms AM; Van Riel PL; Borm GF; Van de Putte LB; Van der Meer JW
    Br J Rheumatol; 1995 Aug; 34(8):747-55. PubMed ID: 7551660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of methotrexate chronotherapy in collagen-induced rheumatoid arthritis in rats.
    Wang X; Yan X; Wang F; Ge F; Li Z
    Z Rheumatol; 2018 Apr; 77(3):249-255. PubMed ID: 27900440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults.
    Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H
    J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-23 in early disease development in rheumatoid arthritis.
    Andersen T; Hvid M; Johansen C; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Deleuran B
    Scand J Rheumatol; 2015; 44(6):438-42. PubMed ID: 26087654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.